Manav Chopra of Nirmal Bang recommends buying Biocon for a target price of Rs 520 and Venus Remedies for a target price of Rs 370.
first published: Sep 10, 2014 12:59 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell

Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell

Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more

How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
You are already a Moneycontrol Pro user.

